5Blumenthal SL, McAfee PC, Guyer RD, et al. A prospective, randomized, multi - center FDA IDE study of lumbar total disc replacement with the CHARITETM Artificial Disc vs. lumbar fusion : Part I - evaluation of clinical outcomes[J]. Spine, 2005,30:1565 -1575.
6Lemaire JP, Cartier H, Sarialiel H, et al. Clinical and radiological outcomes with the Charite artificial disc: a 10 -year minimum follow -up[ J]. J Spinal Disord Tech, 2005,18:353 -359.
7Zeegers WS, Bohnen LM, Laaper M, et al. Artificial disc replacement ,with the modular type SB Charite Ⅲ : 2 - year results in 50 prospectively studied patients[ J]. Eur Spine J, 1999,8:210 - 217.
9Ahrens M, Donkersloot P, Maartens F, et al. Nucleus replacement with the DASCOR[ TM ] disc arthroplasty system: two year follow up results obtained from two prospective European multi - center clinical studies[R]. Spine Arthroplasty Society:Berlin,Germany, 2007.
10Jin D, Qu D, Zhao L,et al. Prosthetic disc nucleus (PDN) replacement for lumbar disc herniation [ J ]. J of Spinal Disorders and Techniques, 2003,16:331 - 337.
3[1]Zeegers LM,Bohnen M.Artificial disc replace-ment with the modular type SB CharitéⅢ:2-years results in 50 prospectively studied patients[J].Eur Spine J,1999,8:210～217.
4[2]Lemaire JP,Skalli W.Intervertebral disc prosthesis.Results and prospects for the year 2000[J].Clin Orthop Relat Res,1997,337:64～76.
6[4]Zeegers WS,Bohnen LM,Laaper M,et al.Artificial disc replacement with the modular type SB ChariteⅢ:2-year results in 50 prospectively studied patients[J].Eur Spine J,1999,8:210～217.
7[5]Thierry J.David.Lumbosacral Disc prothesis lumbosacral and spinopelvic Fixation[J].Z Orthop,1996,9:881～887.
8[6]Frymoyer JW.Indications for consideration of the artificial disc[M].In:Weinstein JK(ed)Clinical efficacy and outcone in the diagnosis and treatment of low back pain.Raven Press,New York,1992,8:227～236.
9Lee C K.Accelerated degeneration of the segment adjacent to a lumbar fusion[J].Spine,1998,13:375-377.
10Cinotti G,David T,Postacchini F.Results of disc prosthesis after a minimum follow-up period of 2 years[J].Spine,1996,21(8):995-1000.
